Autumn Spectacular Boost for Rosemere

Autumn Spectacular Boost for Rosemere

Talk about plucky pensioners! Go On Tour theatre group descended on Leyland Fox Lane Sports & Social Club with their 2019 Autumn Spectacular show, and raised almost £550 for the Rosemere Cancer Foundation

Organisers Mandy M Stableford. (Artistic Director) and Keith Bradshaw (Compere) recently returned to the venue to hand over a cheque for £542.54 to Rebecca Arestidou, Rosemere’s Central Area Fundraising Co-ordinator.

Rebecca said: “Well done on another hugely successful fundraiser with GO On Tour. It was a fantastic event, everyone who attended thoroughly enjoyed the entertainment. It was a wonderful amount raised and we are extremely grateful to the group for their ongoing support..”

Mandy Stableford, who is based in Leyland, said: “We are all volunteers and we perform up to 60 shows a year. Every so often we put a show on to raise money for the Rosemere Cancer charity. Over the years we have raised thousands for this worthy local cause.”

The Autumn Spectacular was attended by around 70 enthusiastic guests, including the Mayor and Mayoress of South Ribble, Councillor Harry Hancock and his wife, Marion – both were up and dancing with the Go On Tour group by the end of the show.

A charity raffle was well supported by local businesses, particularly the BB4B (Breakfast Before Business) networking group. This helped to boost the fundraising considerably.

The variety entertainment group GO On Tour are based at Blackburn Empire Theatre. All are over 60 years old and regularly perform at nursing homes, sheltered accommodation, WI, birthday parties, over 50’s groups and many more.

Rosemere Cancer Foundation works to bring world-class cancer treatments and services to cancer patients from throughout Lancashire and South Cumbria being treated at Rosemere Cancer Centre, the region’s specialist cancer treatment centre at the Royal Preston Hospital, and at another eight local hospital cancer units across the two counties. The charity funds cutting edge equipment, research, training and other cancer services and therapies that the NHS is unable to afford.